|
Information, Publications, and Resources by Vaccine/Disease
COVID-19
- https://www.cdc.gov/vaccines/acip/recommendations.html
- https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#immunocompromised
- https://www.cdc.gov/vaccines/covid-19/clinical-considerations/faq.html
- https://www.cdc.gov/vaccines/covid-19/downloads/COVID19-vaccination-recommendations-most-people.pdf
- https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#Interchangeability
- https://www.cdc.gov/media/releases/2024/s-t0627-vaccine-recommendations.html
Flu
Flu Resource Center
Flu Resources
Social media and print resources to share information on the importance of an annual flu vaccine.
Wild to Mild
Access CDC Flu Vaccination Campaign resources to encourage annual flu vaccination.
HPV
HPV Vaccination Recommendations
Last Updated: Aug 2024
For adults ages 27 through 45 years, clinicians can consider discussing HPV vaccination with people who are most likely to benefit. HPV vaccination does not need to be discussed with most adults over age 26 years.
Hepatitis B
Hepatitis B Resources for Health Care Professionals
https://www.cdc.gov/hepatitis-b/hcp/provider-resources/index.html
Hepatitis Basics
https://www.cdc.gov/hepatitis-b/about/?CDC_AAref_Val=https://www.cdc.gov/hepatitis/hbv/bfaq.htm
Meningococcal
Meningococcal Vaccine Recommendations
Last Updated: Aug 2024
CDC recommends meningococcal vaccination for all adolescents and individuals at increased risk.Read more
Meningococcal Vaccine Resources
Last Updated: Aug 2024
Meningococcal vaccine resources including: provider education courses, provider fact sheets, vaccination schedules, provider, parent and patient education materials, references and resources
Mpox
Mpox Vaccination
Last Updated: Aug 2024
Vaccination. Print. Administration of more than 2 doses of JYNNEOS vaccine (“boosters”) is currently not recommended except for certain people who work with orthopoxviruses in research or mpox diagnostic laboratories.
Pneumococcal
Pneumococcal Vaccine Recommendations
Job aids for adult pneumococcal vaccination
- Shared clinical decision-making: This job aid should assist vaccine providers in discussions with older adults considering PCV20 or PCV21 vaccination.
- Vaccine timing for adults: This job aid should help vaccine providers interpret adult pneumococcal vaccine recommendations.
Contraindications and precautions
General Best Practice Guidelines for Immunization
Pink Book chapter on pneumococcal disease
Immunization schedules
Adult immunization schedule
Pneumococcal Vaccine Information Statements
PCV: English | Other languages
PPSV23: English | Other languages
[PDF Complete ]Pneumococcal Vaccine Schedules for Adults Last Updated: Sept 12 2024
Complete pneumococcal vaccine schedules for adults based on age, underlying risk factor, and previously received pneumococcal vaccines.
Chapter 17: Pneumococcal Disease | Pink Book Last Updated: Jul 2024
Read about pneumococcal disease and vaccination, including vaccine safety, efficacy, and reporting
RSV
Frequently Asked Questions About RSV Vaccine for Pregnant People Last Updated: Aug 2024
Frequently Asked Questions About RSVpreF (Abrysvo) Vaccine for Pregnant People. Print. Avoid potential vaccination errors – Pregnant people should ONLY receive Pfizer RSVpreF (ABRYSVO) vaccine. RSVpreF (Abrysvo) vaccine is the ONLY
ACIP Evidence to Recommendations for Use of Pfizer RSVpreF in Pregnant People Last Updated: Aug 2024
ACIP Evidence to Recommendations for Use of Pfizer RSVpreF in Pregnant People. Print. Question: Should Pfizer RSVpreF vaccine be recommended for pregnant people to be given during 32 through 36 weeks gestation to prevent RSV lower
[PDF]RSV Vaccination in Older Adults - Priority questions and discussion topics Last Updated: Aug 2024
RSV Vaccination in Older Adults: Benefit-Risk Discussion Michael Melgar, MD Lauren Roper, MPH Advisory Committee on Immunization Practices February 29, 2024 There are two RSV vaccines approved in the United States
[PDF]RSV Vaccination in Older Adults: Work Group Interpretations Last Updated: Aug 2024
ACIP concluded that the estimated benefits of RSV vaccination outweighed potential risks.
|
